128 related articles for article (PubMed ID: 8194897)
21. Methods and prognostic value of bone marrow examination in small cell carcinoma of the lung.
Kelly BW; Morris JF; Harwood BP; Bruya TE
Cancer; 1984 Jan; 53(1):99-102. PubMed ID: 6317161
[TBL] [Abstract][Full Text] [Related]
22. Bilateral bone-marrow examinations in small-cell anaplastic carcinoma of the lung.
Hirsch FR; Hansen HH; Hainau B
Acta Pathol Microbiol Scand A; 1979 Jan; 87(1):59-62. PubMed ID: 217234
[TBL] [Abstract][Full Text] [Related]
23. Bone marrow micrometastases in advanced stage non-small cell lung carcinoma patients.
Brunsvig PF; Flatmark K; Aamdal S; Høifødt H; Le H; Jakobsen E; Sandstad B; Fodstad O
Lung Cancer; 2008 Aug; 61(2):170-6. PubMed ID: 18261824
[TBL] [Abstract][Full Text] [Related]
24. Bone marrow metastases detection in small cell lung cancer. A review.
Trillet-Lenoir VN; Arpin D; Brune J
Anticancer Res; 1994; 14(6B):2795-7. PubMed ID: 7872720
[TBL] [Abstract][Full Text] [Related]
25. Comparison of immunoreactivity between two different monoclonal antibodies recognizing peptide and polysialic acid chain epitopes on the neural cell adhesion molecule in normal tissues and lung tumors.
Tome Y; Hirohashi S; Noguchi M; Matsuno Y; Shimosato Y
Acta Pathol Jpn; 1993 Apr; 43(4):168-75. PubMed ID: 7684180
[TBL] [Abstract][Full Text] [Related]
26. Preservation of cluster 1 small cell lung cancer antigen in zinc-formalin fixative and its application to immunohistological diagnosis.
Tome Y; Hirohashi S; Noguchi M; Shimosato Y
Histopathology; 1990 May; 16(5):469-74. PubMed ID: 2163357
[TBL] [Abstract][Full Text] [Related]
27. Tumor seeding associated with bone marrow aspiration and biopsy.
Citron ML; Krasnow SH; Grant C; Cohen MH
Arch Intern Med; 1984 Jan; 144(1):177. PubMed ID: 6318678
[TBL] [Abstract][Full Text] [Related]
28. Patterns of bone marrow involvement with small cell lung cancer.
Clamon GH; Edwards WR; Hamous JE; Scupham RK
Cancer; 1984 Jul; 54(1):100-2. PubMed ID: 6326994
[TBL] [Abstract][Full Text] [Related]
29. Immunocytological detection of residual marrow disease at clinical remission predicts metastatic relapse in small cell lung cancer.
Leonard RC; Duncan LW; Hay FG
Cancer Res; 1990 Oct; 50(20):6545-8. PubMed ID: 2170006
[TBL] [Abstract][Full Text] [Related]
30. Detection of small cell lung cancer bone marrow involvement by discontinuous gradient sedimentation.
Hunter RF; Broadway P; Sun SL; Niell HB; Mauer AM
Cancer Res; 1987 May; 47(10):2737-40. PubMed ID: 3032414
[TBL] [Abstract][Full Text] [Related]
31. Immunocytological detection of bone marrow micrometastasis in operable non-small cell lung cancer.
Pantel K; Izbicki JR; Angstwurm M; Braun S; Passlick B; Karg O; Thetter O; Riethmüller G
Cancer Res; 1993 Mar; 53(5):1027-31. PubMed ID: 7679945
[TBL] [Abstract][Full Text] [Related]
32. Detection of occult micrometastases in the bone marrow of patients with prostate carcinoma.
Bretton PR; Melamed MR; Fair WR; Cote RJ
Prostate; 1994 Aug; 25(2):108-14. PubMed ID: 7518596
[TBL] [Abstract][Full Text] [Related]
33. Bone marrow micrometastases in breast cancer patients.
Molino A; Pelosi G; Micciolo R; Turazza M; Nortilli R; Pavanel F; Cetto GL
Breast Cancer Res Treat; 1999 Nov; 58(2):123-30. PubMed ID: 10674876
[TBL] [Abstract][Full Text] [Related]
34. The value of the bone scan and bone marrow biopsy staging small cell lung cancer.
Levitan N; Byrne RE; Bromer RH; Faling LJ; Caslowitz P; Pattern DH; Hong WK
Cancer; 1985 Aug; 56(3):652-4. PubMed ID: 2988751
[TBL] [Abstract][Full Text] [Related]
35. Is bone marrow examination in small-cell lung cancer really necessary?
Campling B; Quirt I; DeBoer G; Feld R; Shepherd FA; Evans WK
Ann Intern Med; 1986 Oct; 105(4):508-12. PubMed ID: 3019199
[TBL] [Abstract][Full Text] [Related]
36. Immunocytochemical detection of breast cancer cells in marrow and peripheral blood of patients undergoing high dose chemotherapy with autologous stem cell support.
Franklin WA; Shpall EJ; Archer P; Johnston CS; Garza-Williams S; Hami L; Bitter MA; Bast RC; Jones RB
Breast Cancer Res Treat; 1996; 41(1):1-13. PubMed ID: 8932871
[TBL] [Abstract][Full Text] [Related]
37. Eradication of small cell lung cancer cells from human bone marrow with immunotoxins.
Myklebust AT; Godal A; Pharo A; Juell S; Fodstad O
Cancer Res; 1993 Aug; 53(16):3784-8. PubMed ID: 8393381
[TBL] [Abstract][Full Text] [Related]
38. In vivo and in vitro growth of SCLC cells derived from biopsies.
Gianì S; Bedini V; Cataldo I; Iafrate E; Martignone S; Ménard S; Pilotti S; Pratesi G; Soresi E; Colnaghi MI
Tumori; 1989 Dec; 75(6):570-5. PubMed ID: 2559524
[TBL] [Abstract][Full Text] [Related]
39. Histopathological characterization of a novel monoclonal antibody, MLuC1, reacting with lung carcinomas.
Agresti R; Alzani R; Andreola S; Bedini V; Gianì S; Ménard S; Rilke F; Colnaghi MI
Tumori; 1988 Aug; 74(4):401-10. PubMed ID: 2847384
[TBL] [Abstract][Full Text] [Related]
40. Blood group A cross-reacting epitope defined by monoclonal antibodies NCC-LU-35 and -81 expressed in cancer of blood group O or B individuals: its identification as Tn antigen.
Hirohashi S; Clausen H; Yamada T; Shimosato Y; Hakomori S
Proc Natl Acad Sci U S A; 1985 Oct; 82(20):7039-43. PubMed ID: 2413456
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
